Wu Y - Search Results

1

Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus.

Zhang F, Wu L, Qian J, Qu B, Xia S, La T, Wu Y, Ma J, Zeng J, Guo Q, Cui Y, Yang W, Huang J, Zhu W, Yao Y, Shen N, Tang Y. Zhang F, et al. Among authors: wu y, wu l. J Autoimmun. 2016 Dec;75:96-104. doi: 10.1016/j.jaut.2016.07.012. Epub 2016 Jul 29. J Autoimmun. 2016. PMID: 27481557

2

Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus.

Wu Y, Zhang F, Ma J, Zhang X, Wu L, Qu B, Xia S, Chen S, Tang Y, Shen N. Wu Y, et al. Among authors: wu l. Arthritis Res Ther. 2015 May 21;17(1):131. doi: 10.1186/s13075-015-0632-3. Arthritis Res Ther. 2015. PMID: 25994030 Free PMC article.

3

miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells.

Zhang X, Han X, Tang Y, Wu Y, Qu B, Shen N. Zhang X, et al. Among authors: wu y. Sci Rep. 2015 Aug 11;5:12987. doi: 10.1038/srep12987. Sci Rep. 2015. PMID: 26259828 Free PMC article.

4

Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.

Wu L, Qin Y, Xia S, Dai M, Han X, Wu Y, Zhang X, Ma J, Wang Y, Tang Y, Liu Z, Zhu W, Jallal B, Yao Y, Qu B, Shen N. Wu L, et al. Among authors: wu y. Arthritis Rheumatol. 2016 May;68(5):1222-32. doi: 10.1002/art.39543. Arthritis Rheumatol. 2016. PMID: 26663909

5

Construction of competing endogenous RNA networks in systemic lupus erythematosus by integrated analysis.

He J, Dai Y, Liu J, Lin H, Gao F, Chen Z, Wu Y. He J, et al. Among authors: wu y. Front Med (Lausanne). 2024 May 20;11:1383186. doi: 10.3389/fmed.2024.1383186. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38835801 Free PMC article.

6

Comprehensive analysis of ferroptosis-related hub gene signatures as a potential pathogenesis and therapeutic target for systemic sclerosis: A bioinformatics analysis.

Wu C, Liu J, Chen Z, Wu Y, Gao F. Wu C, et al. Among authors: wu y. Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231187783. doi: 10.1177/03946320231187783. Int J Immunopathol Pharmacol. 2023. PMID: 37403234 Free PMC article.

7

Exploring the XIST axis as oxidative stress-related signatures in systemic lupus erythematosus.

Chen Z, Dai Y, Lai Y, Gao F, Wu Y. Chen Z, et al. Among authors: wu y. Clin Exp Rheumatol. 2024 Jan;42(1):145-156. doi: 10.55563/clinexprheumatol/e42fho. Epub 2023 Aug 29. Clin Exp Rheumatol. 2024. PMID: 37650299

8

Tofacitinib therapy in systemic lupus erythematosus with arthritis: a retrospective study.

Yan Q, Liu J, Long X, Wu C, Lin D, Wu Y, Gao F, Zhang L, Chen N. Yan Q, et al. Among authors: wu y, wu c. Clin Rheumatol. 2024 Oct;43(10):3139-3145. doi: 10.1007/s10067-024-07103-2. Epub 2024 Aug 13. Clin Rheumatol. 2024. PMID: 39136836

9

The clinical and pathological significance of tertiary lymphoid structure in extramammary Paget's disease.

Xi N, Xu X, Xu M, Wu N, Wu Y, Chen J, Liu S, Jiang L, Yan G, Zhang G, Liu Y. Xi N, et al. Among authors: wu y. Front Immunol. 2024 Nov 15;15:1435629. doi: 10.3389/fimmu.2024.1435629. eCollection 2024. Front Immunol. 2024. PMID: 39620222 Free PMC article.

10

Triterpenoids from Ganoderma lucidum inhibit cytochrome P450 enzymes interfering with the metabolic process of specific clinical drugs.

Li D, Lin Y, Lv X, Wu Y, Han C, Cao P, Zhang G, Leng A, Zhou J, Wang C. Li D, et al. Among authors: wu y. Front Pharmacol. 2024 Nov 15;15:1485209. doi: 10.3389/fphar.2024.1485209. eCollection 2024. Front Pharmacol. 2024. PMID: 39619618 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84,673 results

Search Page

Filters